Financhill
Sell
26

XRAY Quote, Financials, Valuation and Earnings

Last price:
$16.11
Seasonality move :
0.9%
Day range:
$16.20 - $16.73
52-week range:
$12.16 - $27.95
Dividend yield:
3.9%
P/E ratio:
--
P/S ratio:
0.89x
P/B ratio:
1.63x
Volume:
1.5M
Avg. volume:
2.9M
1-year change:
-39.33%
Market cap:
$3.3B
Revenue:
$3.8B
EPS (TTM):
-$4.54

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XRAY
Dentsply Sirona
$853.9M $0.30 -5.77% 234.18% $18.14
ALGN
Align Technology
$975.8M $1.99 2.9% 100.44% $227.30
BIOLQ
Biolase
$13.5M -$0.01 3.78% -99.71% $1.2000
MLSS
Milestone Scientific
$2.5M -$0.01 40.26% -50% $2.13
NVST
Envista Holdings
$606.4M $0.20 0.62% 46.34% $19.04
SOLV
Solventum
$2B $1.22 1.89% 185.16% $82.17
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XRAY
Dentsply Sirona
$16.41 $18.14 $3.3B -- $0.16 3.9% 0.89x
ALGN
Align Technology
$188.07 $227.30 $13.6B 34.26x $0.00 0% 3.52x
BIOLQ
Biolase
$0.0092 $1.2000 $336.7K -- $0.00 0% 0.00x
MLSS
Milestone Scientific
$0.92 $2.13 $71.8M -- $0.00 0% 8.51x
NVST
Envista Holdings
$19.14 $19.04 $3.2B -- $0.00 0% 1.32x
SOLV
Solventum
$75.55 $82.17 $13.1B 34.98x $0.00 0% 1.58x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XRAY
Dentsply Sirona
53.74% 1.023 78.42% 0.56x
ALGN
Align Technology
-- 2.173 -- 0.99x
BIOLQ
Biolase
142.17% -4.491 714.45% 0.23x
MLSS
Milestone Scientific
-- 1.937 -- 0.62x
NVST
Envista Holdings
31.74% 1.812 47.7% 1.68x
SOLV
Solventum
70.81% 0.887 60.15% 0.64x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XRAY
Dentsply Sirona
$466M $70M -19.2% -35.57% 7.17% -$12M
ALGN
Align Technology
$680.1M $135.3M 10.72% 10.72% 13.81% $27.4M
BIOLQ
Biolase
$4.4M -$695K -129.74% -21668.17% -7.48% -$4.5M
MLSS
Milestone Scientific
$1.6M -$2M -79.98% -79.98% -89.49% -$1M
NVST
Envista Holdings
$336M $47.4M -24.02% -34.78% 6.21% -$5.6M
SOLV
Solventum
$1.1B $152M 3.34% 11.75% 6.86% -$80M

Dentsply Sirona vs. Competitors

  • Which has Higher Returns XRAY or ALGN?

    Align Technology has a net margin of 2.28% compared to Dentsply Sirona's net margin of 9.52%. Dentsply Sirona's return on equity of -35.57% beat Align Technology's return on equity of 10.72%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
  • What do Analysts Say About XRAY or ALGN?

    Dentsply Sirona has a consensus price target of $18.14, signalling upside risk potential of 10.56%. On the other hand Align Technology has an analysts' consensus of $227.30 which suggests that it could grow by 20.86%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 13 0
    ALGN
    Align Technology
    8 6 0
  • Is XRAY or ALGN More Risky?

    Dentsply Sirona has a beta of 0.948, which suggesting that the stock is 5.215% less volatile than S&P 500. In comparison Align Technology has a beta of 1.643, suggesting its more volatile than the S&P 500 by 64.323%.

  • Which is a Better Dividend Stock XRAY or ALGN?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 3.9%. Align Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Align Technology pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or ALGN?

    Dentsply Sirona quarterly revenues are $879M, which are smaller than Align Technology quarterly revenues of $979.3M. Dentsply Sirona's net income of $20M is lower than Align Technology's net income of $93.2M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Align Technology's PE ratio is 34.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.89x versus 3.52x for Align Technology. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.89x -- $879M $20M
    ALGN
    Align Technology
    3.52x 34.26x $979.3M $93.2M
  • Which has Higher Returns XRAY or BIOLQ?

    Biolase has a net margin of 2.28% compared to Dentsply Sirona's net margin of -13.16%. Dentsply Sirona's return on equity of -35.57% beat Biolase's return on equity of -21668.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
    BIOLQ
    Biolase
    40.39% -$0.04 $12.4M
  • What do Analysts Say About XRAY or BIOLQ?

    Dentsply Sirona has a consensus price target of $18.14, signalling upside risk potential of 10.56%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 21639.13%. Given that Biolase has higher upside potential than Dentsply Sirona, analysts believe Biolase is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 13 0
    BIOLQ
    Biolase
    1 1 0
  • Is XRAY or BIOLQ More Risky?

    Dentsply Sirona has a beta of 0.948, which suggesting that the stock is 5.215% less volatile than S&P 500. In comparison Biolase has a beta of -0.033, suggesting its less volatile than the S&P 500 by 103.32%.

  • Which is a Better Dividend Stock XRAY or BIOLQ?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 3.9%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or BIOLQ?

    Dentsply Sirona quarterly revenues are $879M, which are larger than Biolase quarterly revenues of $10.9M. Dentsply Sirona's net income of $20M is higher than Biolase's net income of -$1.4M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.89x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.89x -- $879M $20M
    BIOLQ
    Biolase
    0.00x -- $10.9M -$1.4M
  • Which has Higher Returns XRAY or MLSS?

    Milestone Scientific has a net margin of 2.28% compared to Dentsply Sirona's net margin of -89.35%. Dentsply Sirona's return on equity of -35.57% beat Milestone Scientific's return on equity of -79.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
    MLSS
    Milestone Scientific
    73.8% -$0.02 $4.5M
  • What do Analysts Say About XRAY or MLSS?

    Dentsply Sirona has a consensus price target of $18.14, signalling upside risk potential of 10.56%. On the other hand Milestone Scientific has an analysts' consensus of $2.13 which suggests that it could grow by 132.24%. Given that Milestone Scientific has higher upside potential than Dentsply Sirona, analysts believe Milestone Scientific is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 13 0
    MLSS
    Milestone Scientific
    1 0 0
  • Is XRAY or MLSS More Risky?

    Dentsply Sirona has a beta of 0.948, which suggesting that the stock is 5.215% less volatile than S&P 500. In comparison Milestone Scientific has a beta of 0.902, suggesting its less volatile than the S&P 500 by 9.838%.

  • Which is a Better Dividend Stock XRAY or MLSS?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 3.9%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or MLSS?

    Dentsply Sirona quarterly revenues are $879M, which are larger than Milestone Scientific quarterly revenues of $2.2M. Dentsply Sirona's net income of $20M is higher than Milestone Scientific's net income of -$2M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.89x versus 8.51x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.89x -- $879M $20M
    MLSS
    Milestone Scientific
    8.51x -- $2.2M -$2M
  • Which has Higher Returns XRAY or NVST?

    Envista Holdings has a net margin of 2.28% compared to Dentsply Sirona's net margin of 2.92%. Dentsply Sirona's return on equity of -35.57% beat Envista Holdings's return on equity of -34.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
    NVST
    Envista Holdings
    54.47% $0.10 $4.4B
  • What do Analysts Say About XRAY or NVST?

    Dentsply Sirona has a consensus price target of $18.14, signalling upside risk potential of 10.56%. On the other hand Envista Holdings has an analysts' consensus of $19.04 which suggests that it could fall by -0.51%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 13 0
    NVST
    Envista Holdings
    4 9 1
  • Is XRAY or NVST More Risky?

    Dentsply Sirona has a beta of 0.948, which suggesting that the stock is 5.215% less volatile than S&P 500. In comparison Envista Holdings has a beta of 0.995, suggesting its less volatile than the S&P 500 by 0.5%.

  • Which is a Better Dividend Stock XRAY or NVST?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 3.9%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or NVST?

    Dentsply Sirona quarterly revenues are $879M, which are larger than Envista Holdings quarterly revenues of $616.9M. Dentsply Sirona's net income of $20M is higher than Envista Holdings's net income of $18M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.89x versus 1.32x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.89x -- $879M $20M
    NVST
    Envista Holdings
    1.32x -- $616.9M $18M
  • Which has Higher Returns XRAY or SOLV?

    Solventum has a net margin of 2.28% compared to Dentsply Sirona's net margin of 6.62%. Dentsply Sirona's return on equity of -35.57% beat Solventum's return on equity of 11.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
    SOLV
    Solventum
    53.82% $0.78 $11.2B
  • What do Analysts Say About XRAY or SOLV?

    Dentsply Sirona has a consensus price target of $18.14, signalling upside risk potential of 10.56%. On the other hand Solventum has an analysts' consensus of $82.17 which suggests that it could grow by 8.76%. Given that Dentsply Sirona has higher upside potential than Solventum, analysts believe Dentsply Sirona is more attractive than Solventum.

    Company Buy Ratings Hold Ratings Sell Ratings
    XRAY
    Dentsply Sirona
    2 13 0
    SOLV
    Solventum
    1 8 0
  • Is XRAY or SOLV More Risky?

    Dentsply Sirona has a beta of 0.948, which suggesting that the stock is 5.215% less volatile than S&P 500. In comparison Solventum has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock XRAY or SOLV?

    Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 3.9%. Solventum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Solventum pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XRAY or SOLV?

    Dentsply Sirona quarterly revenues are $879M, which are smaller than Solventum quarterly revenues of $2.1B. Dentsply Sirona's net income of $20M is lower than Solventum's net income of $137M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Solventum's PE ratio is 34.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.89x versus 1.58x for Solventum. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XRAY
    Dentsply Sirona
    0.89x -- $879M $20M
    SOLV
    Solventum
    1.58x 34.98x $2.1B $137M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Planet Labs’ Stock Go Next?
Where Will Planet Labs’ Stock Go Next?

On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
75
INSM alert for Jun 11

Insmed [INSM] is up 7.75% over the past day.

Sell
25
AAON alert for Jun 11

AAON [AAON] is down 3.49% over the past day.

Buy
58
EXOD alert for Jun 11

Exodus Movement [EXOD] is down 8.21% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock